Health Fidelity Announces Board of Advisors

MENLO PARK, Calif., March 20, 2012 /PRNewswire/ -- Health Fidelity, Inc., provider of a breakthrough natural language processing (NLP) platform for healthcare, announced today that it has brought together four industry luminaries to help guide strategic decisions and vision.  Each member of Health Fidelity's Board of Advisors is a recognized leader in healthcare.

(Logo: http://photos.prnewswire.com/prnh/20120306/NY65021LOGO )

The company's Board of Advisors includes:

• Ray Scott, BSc, MBCS, CEng, CITP – Mr. Scott is a world leader in commercial healthcare data management.  He is CEO and Founder of Axolotl, a leading medical electronic connectivity and collaboration firm, and Executive Vice President of Product Strategy of OptumInsight, formerly Ingenix, which acquired Axolotl in August 2010.
• Mark Musen, M.D., PhD – Dr. Musen is a global leader in medical ontologies.  He is Professor of Medicine (Bioinformatics) and Division Head of the Stanford Center for Biomedical Informatics Research (BMIR), and is founder of the National Center for Biomedical Ontology (NCBO).
• Carol Friedman, PhD – Dr. Friedman is a longtime expert in clinical NLP and the developer of MedLEE, a widely used and studied NLP engine on which the Health Fidelity NLP platform is based.  Dr. Friedman is Professor of Biomedical Informatics at the Columbia College of Physicians and Surgeons, Columbia University. 
• Wendy Chapman, PhD – Dr. Chapman is a global leader in clinical NLP. She is Associate Professor of Biomedical Informatics at the University of California San Diego and is Chair of the American Medical Informatics Association (AMIA) NLP Committee.

"The expertise Ray, Mark, Carol, and Wendy bring will support Health Fidelity as a leader in clinical natural language processing," said Dan Riskin, CEO and Founder of Health Fidelity.  "All of them are recognized leaders in their fields, and we are honored they are serving as our advisors."

In January, Health Fidelity announced an exclusive license to commercialize Columbia University's MedLEE NLP technology in healthcare.  In February, Health Fidelity announced that it had closed a Series A financing round led by Charter Life Sciences of Santa Clara, Calif.  

About Health Fidelity
Health Fidelity, Inc., based in Menlo Park, Calif., elevates the standard of care by extracting value from the vast unstructured clinical data that healthcare organizations capture but cannot utilize.  With its breakthrough natural language processing (NLP) platform, incorporating the world's most accurate, reliable and studied NLP technology, Health Fidelity partners with HIT solution companies to enable healthcare organizations to utilize their previously untapped content.  Health Fidelity's secure cloud-based integration enables real-time automated extraction and encoding of unstructured information for analysis, exchange, and regulatory compliance.  By leveraging the previously untapped data within clinician notes, healthcare payers, providers and pharmaceutical companies can deliver better information to clinicians for more informed medical decision-making.  Additionally, healthcare administrators will have a more complete set of facts they can use to drive operational efficiency and quality.  End-users can make better medical decisions, monitor and improve the quality of care, and enable R&D, thus accelerating the evolution of healthcare. 

For more information about Health Fidelity and its solution partner program, visit www.healthfidelity.com.  For partnership inquiries, contact Lauryn Jones at [email protected].

Media Contact
Christopher Capot
KNB Communications
203-379-8019, [email protected]

SOURCE Health Fidelity, Inc.